Trial Profile
A study investigating relationship AV-1451 PET Tau SUVR and Neuropsychological Assessments in Patients with Progressive Supranuclear Palsy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Progressive supranuclear palsy
- Focus Diagnostic use
- 04 Oct 2018 New trial record